Smith ME - Search Results

1

Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.

Gobbini MI, Smith ME, Richert ND, Frank JA, McFarland HF. Gobbini MI, et al. Among authors: smith me. J Neuroimmunol. 1999 Sep 1;99(1):142-9. doi: 10.1016/s0165-5728(99)00039-9. J Neuroimmunol. 1999. PMID: 10496187

2

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

McFarland HF, Frank JA, Albert PS, Smith ME, Martin R, Harris JO, Patronas N, Maloni H, McFarlin DE. McFarland HF, et al. Among authors: smith me. Ann Neurol. 1992 Dec;32(6):758-66. doi: 10.1002/ana.410320609. Ann Neurol. 1992. PMID: 1471866

3

Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis.

Stone LA, Albert PS, Smith ME, DeCarli C, Armstrong MR, McFarlin DE, Frank JA, McFarland HF. Stone LA, et al. Among authors: smith me. Neurology. 1995 Oct;45(10):1808-14. doi: 10.1212/wnl.45.10.1808. Neurology. 1995. PMID: 7477973

4

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis.

Stone LA, Frank JA, Albert PS, Bash C, Smith ME, Maloni H, McFarland HF. Stone LA, et al. Among authors: smith me. Ann Neurol. 1995 May;37(5):611-9. doi: 10.1002/ana.410370511. Ann Neurol. 1995. PMID: 7755356 Clinical Trial.

5

Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age.

Stone LA, Smith ME, Albert PS, Bash CN, Maloni H, Frank JA, McFarland HF. Stone LA, et al. Among authors: smith me. Neurology. 1995 Jun;45(6):1122-6. doi: 10.1212/wnl.45.6.1122. Neurology. 1995. PMID: 7783875

6

Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: implications for treatment trials.

Frank JA, Stone LA, Smith ME, Albert PS, Maloni H, McFarland HF. Frank JA, et al. Among authors: smith me. Ann Neurol. 1994;36 Suppl:S86-90. doi: 10.1002/ana.410360719. Ann Neurol. 1994. PMID: 8017894

7

Time series for modelling counts from a relapsing-remitting disease: application to modelling disease activity in multiple sclerosis.

Albert PS, McFarland HF, Smith ME, Frank JA. Albert PS, et al. Among authors: smith me. Stat Med. 1994 Mar 15-Apr 15;13(5-7):453-66. doi: 10.1002/sim.4780130509. Stat Med. 1994. PMID: 8023028

8

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.

Smith ME, Stone LA, Albert PS, Frank JA, Martin R, Armstrong M, Maloni H, McFarlin DE, McFarland HF. Smith ME, et al. Ann Neurol. 1993 May;33(5):480-9. doi: 10.1002/ana.410330511. Ann Neurol. 1993. PMID: 8498825

9

Systemic histiocytosis presenting as multiple sclerosis.

Smith ME, Katz DA, Harris JO, Frank JA, Kufta CV, McFarlin DE. Smith ME, et al. Ann Neurol. 1993 May;33(5):549-54. doi: 10.1002/ana.410330521. Ann Neurol. 1993. PMID: 8498832

10

Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS. Smith ME, et al. Am J Pathol. 1999 Oct;155(4):1147-61. doi: 10.1016/S0002-9440(10)65218-2. Am J Pathol. 1999. PMID: 10514398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,568 results

Search Page

Filters